{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:08:50Z","timestamp":1721693330370},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s11894-005-0021-1","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T18:37:27Z","timestamp":1179599847000},"page":"289-296","source":"Crossref","is-referenced-by-count":4,"title":["Frontiers in functional dyspepsia"],"prefix":"10.1007","volume":"7","author":[{"given":"Noel R.","family":"Fajardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Cremonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"21_CR1","volume-title":"Rome II. The Functional Gastrointestinal Disorders: A Multinational Consensus.","author":"DA Drossman","year":"2000","unstructured":"Drossman DA, Corazziari E, Talley NJ, et al.: Diagnosis, pathophysiology and treatment. In Rome II. The Functional Gastrointestinal Disorders: A Multinational Consensus. Edited by Drossman DA. McLean, VA: Degnon Associates; 2000."},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0016-5085(92)90175-X","volume":"102","author":"NJ Talley","year":"1992","unstructured":"Talley NJ, O\u2019Keefe EA, Zinsmeister AR, Melton LJ III: Prevalence of gastrointestinal symptoms in the elderly: a populationbased study. Gastroenterology 1992, 102:895\u2013901.","journal-title":"Gastroenterology"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1023\/A:1016471923384","volume":"47","author":"YC Shih","year":"2002","unstructured":"Shih YC, Barghout VE, Sandler RS, et al.: Resource utilization associated with irritable bowel syndrome in the United States 1987\u20131997. Dig Dis Sci 2002, 47:1705\u20131715.","journal-title":"Dig Dis Sci"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0016-5085(94)90228-3","volume":"107","author":"NJ Talley","year":"1994","unstructured":"Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III: Gastrointestinal tract symptoms and self-reported abuse: a populationbased study. Gastroenterology 1994, 107:1040\u20131049.","journal-title":"Gastroenterology"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/S0002-9270(01)03242-7","volume":"96","author":"L Agreus","year":"2001","unstructured":"Agreus L, Svardsudd K, Talley NJ, et al.: Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001, 96:2905\u20132914.","journal-title":"Am J Gastroenterol"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1016\/S0016-5085(08)80256-9","volume":"120","author":"GR III Locke","year":"2001","unstructured":"Locke GR III, Fett SL, Zinsmeister AR: Transition probabilities between functional gastrointestinal disorders in the community. Gastroenterology 2001, 120:A52.","journal-title":"Gastroenterology"},{"key":"21_CR7","first-page":"954","volume":"92","author":"G Holtmann","year":"1997","unstructured":"Holtmann G, Goebell H, Talley NJ: Functional dyspepsia and irritable bowel syndrome: Is there a common pathophysiological basis? Am J Gastroenterol 1997, 92:954\u2013959.","journal-title":"Am J Gastroenterol"},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2002.07062.x","volume":"97","author":"V Stanghellini","year":"2002","unstructured":"Stanghellini V, Tosetti C, Barbara G, et al.: Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 2002, 97:2738\u20132743.","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 7","key":"21_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2036.2004.02184.x","volume":"20","author":"F Cremonini","year":"2004","unstructured":"Cremonini F, Talley NJ: Review article: The overlap between functional dyspepsia and irritable bowel syndrome: a tale of one or two disorders? Aliment Pharmacol Ther 2004, 20(Suppl 7):40\u201349.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.1995.tb00359.x","volume":"9","author":"NJ Talley","year":"1995","unstructured":"Talley NJ: Review article: Functional dyspepsia: Should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995, 9:107\u2013115.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"G309","DOI":"10.1152\/ajpgi.00242.2002","volume":"285","author":"M Simren","year":"2003","unstructured":"Simren M, Vos R, Janssens J, Tack J: Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2003, 285:G309-G315.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"21_CR12","first-page":"G278","volume":"286","author":"KJ Lee","year":"2003","unstructured":"Lee KJ, Vos R, Janssens J, Tack J: Influence of duodenal acidification on the sensorimotor function of the proximal stomach in man. Am J Physiol Gastrointest Liver Physiol 2003, 2004, 286:G278-G284. Epub 2003 May 21.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"21_CR13","first-page":"G1501","volume":"276","author":"YX Lu","year":"1999","unstructured":"Lu YX, Owyang C: Duodenal acid-induced gastric relaxation is mediated by multiple pathways. Am J Physiol 1999, 276:G1501-G1506.","journal-title":"Am J Physiol"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004, 127:1239\u20131255.","journal-title":"Gastroenterology"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V Stanghellini","year":"1996","unstructured":"Stanghellini V, Tosetti C, Paternico A, et al.: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110:1036\u20131042.","journal-title":"Gastroenterology"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1572-0241.1999.01281.x","volume":"94","author":"V Stanghellini","year":"1999","unstructured":"Stanghellini V, Tosetti C, Paternico A, et al.: Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999, 94:2080\u20132085.","journal-title":"Am J Gastroenterol"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00004836-198912000-00005","volume":"11","author":"NJ Talley","year":"1989","unstructured":"Talley NJ, Shuter B, McCrudden G, et al.: Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J Clin Gastroenterol 1989, 11:625\u2013630.","journal-title":"J Clin Gastroenterol"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","volume":"94","author":"G Sarnelli","year":"2003","unstructured":"Sarnelli G, Caenepeel P, Geypens P, et al.: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003, 94:783\u2013788.","journal-title":"Am J Gastroenterol"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/gut.35.3.327","volume":"35","author":"LE Troncon","year":"1994","unstructured":"Troncon LE, Bennett RJ, Ahluwalia NK, Thompson DG: Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994, 35:327\u2013332.","journal-title":"Gut"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346\u20131352.","journal-title":"Gastroenterology"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1572-0241.2002.05421.x","volume":"97","author":"GE Boeckxstaens","year":"2002","unstructured":"Boeckxstaens GE, Hirsch DP, Kuiken SD, et al.: The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002, 97:40\u201348.","journal-title":"Am J Gastroenterol"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2982.2004.00497.x","volume":"16","author":"H Schepper De","year":"2004","unstructured":"De Schepper H, Cremonini F, Chitkara DK, Camilleri M: Assessment of gastric accommodtion: overview and evaluation of current methods. Neurogastroenterol Motil 2004, 16:275\u2013285.","journal-title":"Neurogastroenterol Motil"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1053\/gast.2002.33584","volume":"122","author":"EA Mayer","year":"2002","unstructured":"Mayer EA, Collins SM: Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002, 122:2032\u20132048.","journal-title":"Gastroenterology"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0016-5085(91)90726-2","volume":"101","author":"F Mearin","year":"1991","unstructured":"Mearin F, Cucala M, Azpiroz F, Malagelada JR: The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991, 101:999\u20131006.","journal-title":"Gastroenterology"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0016-5085(94)90536-3","volume":"107","author":"B Coffin","year":"1994","unstructured":"Coffin B, Azpiroz F, Guarner F, Malagelada JR: Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1994, 107:1345\u20131351.","journal-title":"Gastroenterology"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/BF02212678","volume":"40","author":"KC Trimble","year":"1995","unstructured":"Trimble KC, Farouk R, Pryde A, et al.: Heightened visceral sensation in functional gastrointestinal disease is not sitespecific: evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995, 40:1607\u20131613.","journal-title":"Dig Dis Sci"},{"key":"21_CR27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/gast.2002.33601","volume":"122","author":"M Bouin","year":"2002","unstructured":"Bouin M, Plourde V, Boivin M, et al.: Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002, 122:1771\u20131777.","journal-title":"Gastroenterology"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1053\/j.gastro.2004.09.006","volume":"127","author":"S Delgado-Aros","year":"2004","unstructured":"Delgado-Aros S, Camilleri M, Cremonini F, et al.: Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004, 127:1685\u20131694. Using multiple physiologic tests, this study identifies differential contributions of gastric motor dysfunctions to postprandial symptoms in dyspeptics. The results suggest that accelerated gastric emptying also plays a role.","journal-title":"Gastroenterology"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1572-0241.2004.04003.x","volume":"99","author":"C Feinle-Bisset","year":"2004","unstructured":"Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ: Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004, 99:170\u2013181.","journal-title":"Am J Gastroenterol"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00292.2001","volume":"284","author":"HE Raybould","year":"2003","unstructured":"Raybould HE, Glatzle J, Robin C, et al.: Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 2003, 284:G367-G372.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"R354","DOI":"10.1152\/ajpregu.00705.2003","volume":"287","author":"J Glatzle","year":"2004","unstructured":"Glatzle J, Darcel N, Rechs AJ, et al.: Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway. Am J Physiol Regul Integr Comp Physiol 2004, 287:R354-R359.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00042737-199511000-00007","volume":"7","author":"R Barbera","year":"1995","unstructured":"Barbera R, Feinle C, Read NW: Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995, 7:1051\u20131057.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","volume":"48","author":"C Feinle","year":"2001","unstructured":"Feinle C, Meier O, Otto B, et al.: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48:347\u2013355.","journal-title":"Gut"},{"key":"21_CR34","doi-asserted-by":"crossref","unstructured":"Cremonini F, Camilleri M, Gonenne J, et al.: Somatostatin analog reduces postprandial satiation in obesity. Obes Res 2005, in press.","DOI":"10.1038\/oby.2005.193"},{"key":"21_CR35","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0016-5085(03)00287-7","volume":"124","author":"MP Caldarella","year":"2003","unstructured":"Caldarella MP, Azpiroz F, Malagelada JR: Antro-fundic dysfunctions in functional dyspepsia. Gastroenterology 2003, 124:1220\u20131229.","journal-title":"Gastroenterology"},{"key":"21_CR36","first-page":"2169","volume":"98","author":"M Simren","year":"2003","unstructured":"Simren M, Vos R, Janssens J, Tack J: Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms. Am J Gastroenterol 2003, 98:2169\u20132175.","journal-title":"Am J Gastroenterol"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1572-0241.1999.01362.x","volume":"94","author":"Z Lin","year":"1999","unstructured":"Lin Z, Eaker EY, Sarosiek I, McCallum RW: Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol 1999, 94:2384\u20132389.","journal-title":"Am J Gastroenterol"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/gast.2002.33663","volume":"122","author":"J Tack","year":"2002","unstructured":"Tack J, Demedts I, Dehondt G, et al.: Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002, 122:1738\u20131747.","journal-title":"Gastroenterology"},{"key":"21_CR39","doi-asserted-by":"crossref","unstructured":"Mearin F, Perez-Oliveras M, Perello A, et al.: Dyspepsia after a Salmonella gastroenteritis outbreak: one year follow-up cohort study. Gastroenterology 2005, in press. This study provides the first prospective evidence of a link between an episode of acute gastroenteritis and persistence of functional dyspepsia symptoms.","DOI":"10.1053\/j.gastro.2005.04.012"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/gast.2003.50155","volume":"124","author":"B Fischler","year":"2003","unstructured":"Fischler B, Tack J, De Gucht V, et al.: Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003, 124:903\u2013910.","journal-title":"Gastroenterology"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0950-3528(98)90015-X","volume":"12","author":"G Holtmann","year":"1998","unstructured":"Holtmann G, Stanghellini V, Talley NJ: Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. Baillieres Clin Gastroenterol 1998, 12:417\u2013433.","journal-title":"Baillieres Clin Gastroenterol"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1572-0241.2001.03683.x","volume":"96","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Verlinden M, Jones M: Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001, 96:1422\u20131428.","journal-title":"Am J Gastroenterol"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","volume":"114","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Silverstein MD, Agreus L, et al.: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998, 114:582\u2013595.","journal-title":"Gastroenterology"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1111\/j.1572-0241.1999.01502.x","volume":"94","author":"P Moayyedi","year":"1999","unstructured":"Moayyedi P, Axon AT: The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 1999, 94:3122\u20133125.","journal-title":"Am J Gastroenterol"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/gast.2002.33019","volume":"122","author":"BM Spiegel","year":"2002","unstructured":"Spiegel BM, Vakil NB, Ofman JJ: Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 2002, 122:1270\u20131285.","journal-title":"Gastroenterology"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P Moayyedi","year":"2004","unstructured":"Moayyedi P, Delaney BC, Vakil N, et al.: The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004, 127:1329\u20131337.","journal-title":"Gastroenterology"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/003655202762671260","volume":"37","author":"E Bolling-Sternevald","year":"2002","unstructured":"Bolling-Sternevald E, Lauritsen K, Aalykke C, et al.: Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002, 37:1395\u20131402.","journal-title":"Scand J Gastroenterol"},{"key":"21_CR48","first-page":"623","volume":"83","author":"SK Sarin","year":"1986","unstructured":"Sarin SK, Sharma P, Chawla YK, et al.: Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian J Med Res 1986, 83:623\u2013628.","journal-title":"Indian J Med Res"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01540334","volume":"34","author":"R Jian","year":"1989","unstructured":"Jian R, Ducrot F, Ruskone A, et al.: Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia: a double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989, 34:657\u2013664.","journal-title":"Dig Dis Sci"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/00365529309090256","volume":"28","author":"LP Duan","year":"1993","unstructured":"Duan LP, Zheng ZT, Li YN: A study of gastric emptying in non-ulcer dyspepsia using a new ultrasonographic method. Scand J Gastroenterol 1993, 28:355\u2013360.","journal-title":"Scand J Gastroenterol"},{"key":"21_CR51","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003: CD001960.","DOI":"10.1002\/14651858.CD001960"},{"key":"21_CR52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1572-0241.2001.03521.x","volume":"96","author":"Zanten SJ Veldhuyzen van","year":"2001","unstructured":"Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ: Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001, 96:689\u2013696.","journal-title":"Am J Gastroenterol"},{"key":"21_CR53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000065589","volume":"66","author":"M Alizadeh-Naeeni","year":"2002","unstructured":"Alizadeh-Naeeni M, Saberi-Firoozi M, Pourkhajeh A, et al.: Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia: a randomized, controlled follow-up study. Digestion 2002, 66:92\u201398.","journal-title":"Digestion"},{"key":"21_CR54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365529409090434","volume":"29","author":"I Fumagalli","year":"1994","unstructured":"Fumagalli I, Hammer B: Cisapride versus metoclopramide in the treatment of functional dyspepsia: a double-blind comparative trial. Scand J Gastroenterol 1994, 29:33\u201337.","journal-title":"Scand J Gastroenterol"},{"key":"21_CR55","first-page":"553","volume":"14","author":"A Archimandritis","year":"1992","unstructured":"Archimandritis A, Tzivras M, Fertakis A, et al.: Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia. Clin Ther 1992, 14:553\u2013561.","journal-title":"Clin Ther"},{"key":"21_CR56","first-page":"7","volume":"551","author":"TR Weihrauch","year":"1979","unstructured":"Weihrauch TR, Forster CF, Krieglstein J: Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgrad Med J 1979, 551(Suppl):7\u201310.","journal-title":"Postgrad Med J"},{"issue":"Suppl 1","key":"21_CR57","first-page":"15","volume":"55","author":"R Platteborse","year":"1979","unstructured":"Platteborse R, Hermans C, Loots W, et al.: The effect of domperidone on pyloric activity in dog and in man. Postgrad Med J 1979, 55(Suppl 1):15\u201318.","journal-title":"Postgrad Med J"},{"key":"21_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01318363","volume":"30","author":"M Horowitz","year":"1985","unstructured":"Horowitz M, Harding PE, Chatterton BE, et al.: Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985, 30:1\u20139.","journal-title":"Dig Dis Sci"},{"key":"21_CR59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A, et al.: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 93:160\u2013165.","journal-title":"Am J Gastroenterol"},{"key":"21_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634443","volume":"99","author":"D Loldrup","year":"1989","unstructured":"Loldrup D, Langemark M, Hansen HJ, et al.: Clomipramine and mianserin in chronic idiopathic pain syndrome: a placebo controlled study. Psychopharmacology 1989, 99:1\u20137.","journal-title":"Psychopharmacology"},{"key":"21_CR61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529609006404","volume":"31","author":"L Tanum","year":"1996","unstructured":"Tanum L, Malt UF: A new pharmacologic treatment of functional gastrointestinal disorder: a double-blind placebocontrolled study with mianserin. Scand J Gastroenterol 1996, 31:318\u2013325.","journal-title":"Scand J Gastroenterol"},{"key":"21_CR62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"JL Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108:65\u201372.","journal-title":"Am J Med"},{"key":"21_CR63","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(01)07103-3","volume":"358","author":"NJ Talley","year":"2001","unstructured":"Talley NJ: Serotoninergic neuroenteric modulators. Lancet 2001, 358:2061\u20132068.","journal-title":"Lancet"},{"key":"21_CR64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.178.2.129","volume":"178","author":"C Barbui","year":"2001","unstructured":"Barbui C, Hotopf M: Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br J Psychiatry 2001, 178:129\u2013144.","journal-title":"Br J Psychiatry"},{"key":"21_CR65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2982.2002.00344.x","volume":"14","author":"U Ladabaum","year":"2002","unstructured":"Ladabaum U, Glidden D: Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans. Neurogastroenterol Motil 2002, 14:395\u2013402.","journal-title":"Neurogastroenterol Motil"},{"key":"21_CR66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","volume":"17","author":"J Tack","year":"2003","unstructured":"Tack J, Broekaert D, Coulie B, et al.: Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 2003, 17:603\u2013608.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR67","first-page":"4189","volume":"21","author":"S Harasawa","year":"1993","unstructured":"Harasawa S, Miwa T: Effect of itopride hydrochloride on gastric emptying in chronic gastritis patients. Jpn Pharmacol Ther 1993, 21:4189\u2013193.","journal-title":"Jpn Pharmacol Ther"},{"key":"21_CR68","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1542-3565(04)00391-X","volume":"2","author":"M Camilleri","year":"2004","unstructured":"Camilleri M, McKinzie S, Fox J, et al.: Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2004, 2:895\u2013904.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"21_CR69","first-page":"G373","volume":"276","author":"B Coulie","year":"1999","unstructured":"Coulie B, Tack J, Sifrim D, et al.: Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am J Physiol 1999, 276:G373-G377.","journal-title":"Am J Physiol"},{"key":"21_CR70","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.46.4.468","volume":"46","author":"J Tack","year":"2000","unstructured":"Tack J, Coulie B, Wilmer A, et al.: Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000, 46:468\u2013473.","journal-title":"Gut"},{"key":"21_CR71","first-page":"A","volume":"122","author":"J Tack","year":"2002","unstructured":"Tack J, Vos R, Janssens J, et al.: Influence of tegaserod on proximal gastric sensory and motor function in man. Gastroenterology 2002, 122:A-453.","journal-title":"Gastroenterology"},{"key":"21_CR72","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1046\/j.1365-2036.2001.01103.x","volume":"15","author":"L Degen","year":"2001","unstructured":"Degen L, Matzinger D, Merz M, et al.: Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001, 15:1745\u20131751.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR73","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2000.00854.x","volume":"14","author":"PJ Kahrilas","year":"2000","unstructured":"Kahrilas PJ, Quigley EM, Castell DO, Spechler SJ: The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000, 14:1503\u20131509.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR74","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1053\/gast.2002.30295","volume":"122","author":"J Tack","year":"2002","unstructured":"Tack J, Delia T, Ligozio G, et al.: A phase II placebo controlled randomized trial with tegaserod in functional dyspepsia patients with normal gastric emptying. Gastroenterology 2002, 122:A20.","journal-title":"Gastroenterology"},{"key":"21_CR75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15:525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2036.2002.01144.x","volume":"16","author":"B Kuo","year":"2002","unstructured":"Kuo B, Camilleri M, Burton D, et al.: Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther 2002, 16:225\u2013233.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR77","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1046\/j.1365-2036.2003.01797.x","volume":"18","author":"NS Coleman","year":"2003","unstructured":"Coleman NS, Marciani L, Blackshaw E, et al.: Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther 2003, 18:1039\u20131048.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-003-0005-5","volume":"7","author":"E Chevlen","year":"2003","unstructured":"Chevlen E: Opioids: a review. Current Pain Headache Rep 2003, 7:15\u201323.","journal-title":"Current Pain Headache Rep"},{"key":"21_CR79","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","volume":"63","author":"A Kurz","year":"2003","unstructured":"Kurz A, Sessler DI: Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003, 63:649\u2013671.","journal-title":"Drugs"},{"key":"21_CR80","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1365-2036.1996.109280000.x","volume":"10","author":"B Coffin","year":"1996","unstructured":"Coffin B, Bouhassira D, Chollet R, et al.: Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther 1996, 10:919\u2013925.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR81","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"NW Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664\u2013668.","journal-title":"Gut"},{"key":"21_CR82","doi-asserted-by":"crossref","first-page":"G558","DOI":"10.1152\/ajpgi.00360.2002","volume":"284","author":"S Delgado-Aros","year":"2003","unstructured":"Delgado-Aros S, Chial HJ, Camilleri M, et al.: Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol 2003, 284:G558-G566.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"21_CR83","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa010564","volume":"345","author":"A Taguchi","year":"2001","unstructured":"Taguchi A, Sharma N, Saleem RM, et al.: Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001, 345:935\u2013940.","journal-title":"N Engl J Med"},{"key":"21_CR84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2982.2003.00420.x","volume":"15","author":"J Fioramonti","year":"2003","unstructured":"Fioramonti J, Gaultier E, Toulouse M, et al.: Intestinal antinociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action. Neurogastroenterol Motil 2003, 15:363\u2013369.","journal-title":"Neurogastroenterol Motil"},{"key":"21_CR85","first-page":"758","volume":"6","author":"GA Giardina","year":"2003","unstructured":"Giardina GA, Gagliardi S, Martinelli M: Antagonists at the neurokinin receptors-recent patent literature. Drugs 2003, 6:758\u2013772.","journal-title":"Drugs"},{"key":"21_CR86","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/cncr.11433","volume":"97","author":"S Poli-Bigelli","year":"2003","unstructured":"Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, et al.: Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 2003, 97:3090\u20133098.","journal-title":"Cancer"},{"key":"21_CR87","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.11320","volume":"97","author":"SP Chawla","year":"2003","unstructured":"Chawla SP, Grunberg SM, Gralla RJ, et al.: Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer 2003, 97:2290\u20132300.","journal-title":"Cancer"},{"key":"21_CR88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1345\/aph.1E242","volume":"39","author":"AM Massaro","year":"2005","unstructured":"Massaro AM: Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting. Ann Pharmacother 2005, 39:77\u201385.","journal-title":"Ann Pharmacother"},{"key":"21_CR89","first-page":"143","volume":"43","author":"P Holzer","year":"1991","unstructured":"Holzer P: Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991, 43:143\u2013201.","journal-title":"Pharmacol Rev"},{"key":"21_CR90","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(95)01094-7","volume":"703","author":"A Szallasi","year":"1995","unstructured":"Szallasi A, Nilsson S, Farkas-Szallasi T, et al.: Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 1995, 703:175\u2013183.","journal-title":"Brain Res"},{"key":"21_CR91","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2036.2002.01280.x","volume":"16","author":"M Bortolotti","year":"2002","unstructured":"Bortolotti M, Coccia G, Grossi G, Miglioli M: The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002, 16:1075\u20131082.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR92","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1046\/j.1365-2036.2002.01358.x","volume":"16","author":"SD Kuiken","year":"2002","unstructured":"Kuiken SD, Lei A, Tytgat GN, et al.: Effect of the low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers. Aliment Pharmacol Ther 2002, 16:1955\u20131962.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR93","doi-asserted-by":"crossref","first-page":"G787","DOI":"10.1152\/ajpgi.2001.280.5.G787","volume":"280","author":"AJ Kirkup","year":"2001","unstructured":"Kirkup AJ, Brunsden AM, Grundy D: Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol Gastrointest Liver Physiol 2001, 280:G787-G794.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"21_CR94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(01)01319-X","volume":"429","author":"P Holzer","year":"2001","unstructured":"Holzer P: Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur J Pharmacol 2001, 429:177\u2013193.","journal-title":"Eur J Pharmacol"},{"key":"21_CR95","first-page":"465","volume":"2","author":"D Taggart","year":"1966","unstructured":"Taggart D, Billington BP: Fatty foods and dyspepsia. Lancet 1966, 2:465\u2013466.","journal-title":"Lancet"},{"key":"21_CR96","first-page":"G721","volume":"273","author":"C Feinle","year":"1997","unstructured":"Feinle C, Grundy D, Read NW: Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension. Am J Physiol 1997, 273:G721-G726.","journal-title":"Am J Physiol"},{"key":"21_CR97","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.2000.278.5.R1217","volume":"278","author":"C Feinle","year":"2000","unstructured":"Feinle C, Grundy D, Otto B, Fried M: Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Compar Physiol 2000, 278:R1217-R1223.","journal-title":"Am J Physiol Regul Integr Compar Physiol"},{"key":"21_CR98","doi-asserted-by":"crossref","first-page":"G363","DOI":"10.1152\/ajpgi.00074.2004","volume":"287","author":"EJ Castillo","year":"2004","unstructured":"Castillo EJ, Delgado-Aros S, Camilleri M, et al.: Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2004, 287:G363-G369.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"21_CR99","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1572-0241.2005.41081.x","volume":"100","author":"F Cremonini","year":"2005","unstructured":"Cremonini F, Camilleri M, McKinzie S, et al.: Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol 2005, 100:652\u2013663.","journal-title":"Am J Gastroenterol"},{"key":"21_CR100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","volume":"17","author":"HJ Kim","year":"2003","unstructured":"Kim HJ, Camilleri M, McKinzie S, et al.: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17:895\u2013904.","journal-title":"Aliment Pharmacol Ther"},{"key":"21_CR101","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1572-0241.2000.02015.x","volume":"95","author":"S Nobaek","year":"2000","unstructured":"Nobaek S, Johansson ML, Molin G, et al.: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231\u20131238.","journal-title":"Am J Gastroenterol"},{"key":"21_CR102","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L O\u2019Mahony","year":"2005","unstructured":"O\u2019Mahony L, McCarthy J, Kelly P, et al.: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541\u2013551.","journal-title":"Gastroenterology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-005-0021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-005-0021-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-005-0021-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:03:52Z","timestamp":1559419432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-005-0021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11894-005-0021-1","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}